Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Current Drugs Introduces Next Generation Strategic Information Tool for Pharmaceutical and Biotechnology Companies.


Business Editors/Health/Medical Writers

LONDON--(BUSINESS WIRE)--May 29, 2003

Thomson Continues to Build Integrated Solutions for Life Science Industries

Current Drugs, part of The Thomson Corporation, today announced the launch of the Strategic Drugs database (SDdb), a business analysis and planning solution for strategists in the international bio-pharmaceutical industries.

The first Web-based solution of its kind, SDdb provides the most comprehensive and strategic information available on drugs in development and on the market.

Leveraging additional Thomson information sources, including Thomson Financial Thomson Financial

A major provider of information, analytical tools, and consulting services to the financial community. The firm, a division of Thomson Corporation, is best known to investors for its First Call segment, which publishes consensus earnings
 and Micromedex, it merges scientific and clinical information with marketplace and financial information in order to provide the most complete and holistic Holistic
A practice of medicine that focuses on the whole patient, and addresses the social, emotional, and spiritual needs of a patient as well as their physical treatment.

Mentioned in: Aromatherapy, Stress Reduction, Traditional Chinese Medicine
 view of the market available.

SDdb allows business and marketing executives to analyze current and predicted sales of the leading prescription drugs prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug,  using a rich suite of graphical analysis tools.

In addition, these high-level financial analyses are combined with the ability to drill-down to the underlying fundamental scientific data that defines the sales prospects of drugs on the market today and in the research and development pipeline.

At a time when the pharmaceutical companies are under pressure to bring innovative new products to market with increased efficiency, SDdb helps business and professional customers make better decisions and make them faster.

According to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 industry reports, $73 billion in major drug patents will expire between 2002 and 2007. At the same time, drug exclusivity has decreased dramatically from eight years in the '70s to one year. These and other factors have brought intense pressure and competition to the research and development process and to the efficient and effective introduction of new drugs.

It is in this new environment that products such as the breakthrough SDdb should thrive.

SDdb supplies the intelligence needed to support decision makers by synthesizing and analyzing scientific and commercial information from multiple sources.

By providing a deeper understanding of competing products on the current market and a timely assessment of emerging competitive threats, it creates a new standard for evaluating the competitive environment and for measuring the performance of pharmaceutical companies.

A premium-service version of the SDdb is also available to customers, combining all of the above with a daily monitoring service The general surveillance of known air traffic movements by reference to a radar scope presentation or other means, for the purpose of passing advisory information concerning conflicting traffic or providing navigational assistance. , covering all major scientific journals, news and business sources. Information captured by SDdb editors is then assessed against a SWOT (Strengths, Opportunities, Weaknesses, Threats) analysis of the drug and its nearest competitors.

Customers are then alerted to any new information likely to impact this analysis.

Mike Tansey, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Thomson Scientific Thomson Scientific is one of the five operating divisions of the Thomson Corporation. The Scientific division provides information-based solutions for the Academic, Business and R&D communities. , commented "SDdb represents the next phase of our solutions offering. We already provide information solutions to research scientists, licensing executives, and R&D managers in the pharmaceutical industry. By combining our knowledge of the most significant products emerging from the R&D pipeline with the expertise on marketed-drugs found across Thomson, we bring another unique product to market that will become an essential tool for our customers to use in their planning and analysis work."

About Thomson and Current Drugs

The Thomson Corporation (www.thomson.com), with 2002 revenues of $7.8 billion, is a global leader in providing integrated information solutions to business and professional customers in the fields of healthcare and scientific research, law, tax, accounting, financial services The examples and perspective in this article or section may not represent a worldwide view of the subject.
Please [ improve this article] or discuss the issue on the talk page.
, higher education higher education

Study beyond the level of secondary education. Institutions of higher education include not only colleges and universities but also professional schools in such fields as law, theology, medicine, business, music, and art.
, reference information, corporate training and testing and assessment.

As part of Thomson, Current Drugs is headquartered in London, UK, and provides the international pharmaceutical and biotechnology industry with databases, publications and services that support the development of innovative new medicines in a competitive environment. Its leading product, IDdb, is used daily by thousands of researchers and business managers in pharmaceutical companies worldwide.

The Corporation's common shares are listed on the Toronto and New York stock exchanges New York Stock Exchange (NYSE)

World's largest marketplace for securities. The exchange began as an informal meeting of 24 men in 1792 on what is now Wall Street in New York City.
 (TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
:TOC; NYSE NYSE

See: New York Stock Exchange
:TOC).
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:May 29, 2003
Words:612
Previous Article:Fitch Rates $125M Baptist Health System --Florida-- Bonds Underlying 'A'.
Next Article:Bring Home One of Television's Most Popular and Honored Dramas! ``ER: The Complete First Season'' Debuting on DVD on August 26.
Topics:



Related Articles
NEW DATABASE CONTAINS DRUG DISCOVERY/DEVELOPMENT INFO.
ENHANCED WORKSPACE MANAGER INCLUDES PROPRIETY ANALYSIS TOOLS.
IMS HEALTH Introduces Enhanced Pioneer; Delivers Detailed Insights Into More Than 12,500 Pharmaceutical Compounds Worldwide.
Celera's Paracel Unit Introduces GeneMatcher 2: New Supercomputer for Sequence Similarity Analysis.
PHARMACEUTICAL COMPANIES USE GENOMIC INFORMATION IN R&D.
Sigma-Aldrich and Chromagen Announce Collaborative Agreement to Develop Next-Generation, Fluorescence-Based Assays for Drug Discovery & Life Science...
Gene Logic Launches Next Generation Enterprise Software System--Genesis 2.0; New Data Management Tool Expands Potential of Functional Genomics...
EVOTEC OAI/PANACOS TO DEVELOP ANTI-HIV THERAPIES.
ASTELLAS' SCREENING TRIGGERS MILESTONE PAYMENT TO METABOLEX.
Growing Demand for Computational Chemistry Tools & Services is Creating Commercial Opportunities for Software Providers.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles